About Biosynth Carbosynth
Biosynth Carbosynth is a company based in Guildford (United Kingdom) founded in 1965 was acquired by KKR in November 2021. Biosynth Carbosynth has completed 2 acquisitions, including Aalto Bio Reagents and vivitide. Biosynth Carbosynth operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Curia and AmplifyBio, among others.
- Headquarter Guildford, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biosynth Limited
- Date of Incorporation 06 Apr, 2006
- Jurisdiction NEWBURY, BERKSHIRE
-
Annual Revenue
$23.11 M (USD)-8as on Dec 31, 2020
-
Net Profit
$950.18 K (USD)910as on Dec 31, 2020
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Aalto Bio Reagents
& 1 more
-
Acquired by
KKR
(Nov 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biosynth Carbosynth
Detailed funding history for Biosynth Carbosynth
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Biosynth Carbosynth
Biosynth Carbosynth has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include KKR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked |
Investor details for Biosynth Carbosynth
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biosynth Carbosynth
Biosynth Carbosynth has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Aalto Bio Reagents and vivitide.
Investment portfolio details for Biosynth Carbosynth
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug development services for neoantigen peptides and antibodies are provided.
|
Locked | Locked | 1983 | Locked | |
|
Raw materials are supplied to in-vitro diagnostics and research laboratories.
|
Locked | Locked | 1978 | Locked |
Complete acquisition details for Biosynth Carbosynth
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Biosynth Carbosynth
Detailed financials for Biosynth Carbosynth
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biosynth Carbosynth Comparisons
Peer comparison for Biosynth Carbosynth
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biosynth Carbosynth
Biosynth Carbosynth operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Curia and AmplifyBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing for biologics are provided.
|
Detailed competitors of Biosynth Carbosynth
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biosynth Carbosynth
Complete news archive for Biosynth Carbosynth
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biosynth Carbosynth
Biosynth Carbosynth was founded in 1965.
Biosynth Carbosynth is headquartered in Guildford, United Kingdom.
Urs Spitz is the current CEO of Biosynth Carbosynth.
Annual revenue of Biosynth Carbosynth is $23.11M as on Dec 31, 2020.
Biosynth Carbosynth was established in 1965 and is headquartered in Guildford, United Kingdom. Operations focus on the pharmaceutical and chemical sectors, where drug discovery, manufacturing, supply chain management, and regulatory support services are delivered. Additional services encompass product synthesis and customization for research and industrial applications. The company serves global clients through its integrated facilities and expertise in complex molecule production.
Biosynth Carbosynth has made 2 acquisitions, including Aalto Bio Reagents, and vivitide.
Biosynth Carbosynth has 1 investor. Key investors include KKR.